Calton & Associates, Inc. Gsk PLC Transaction History

Calton & Associates, Inc.

$250 Million
Q3 2024

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 12, 2022	SELL	$42.05 - $47.77 $8,998 - $10,222	-214 Reduced 2.89%	7,203 $313,000
Q1 2022 Apr 12, 2022	SELL	$40.23 - $47.74 $8,408 - $9,977	-209 Reduced 2.74%	7,417 $323,000
Q4 2021 Jan 13, 2022	SELL	$38.88 - $45.31 $23,211 - $27,050	-597 Reduced 7.26%	7,626 $336,000
Q3 2021 Nov 05, 2021	SELL	$38.79 - $43.16 $45,151 - $50,238	-1,164 Reduced 12.4%	8,223 $314,000
Q2 2021 Aug 11, 2021	BUY	$36.52 - $41.46 $2,556 - $2,902	70 Added 0.75%	9,387 $374,000
Q1 2021 May 03, 2021	BUY	$34.27 - $40.01 $5,791 - $6,761	169 Added 1.85%	9,317 $333,000
Q4 2020 Jan 25, 2021	SELL	$34.07 - $39.94 $46,880 - $54,957	-1,376 Reduced 13.07%	9,148 $337,000
Q3 2020 Oct 30, 2020	SELL	$38.11 - $42.99 $12,347 - $13,928	-324 Reduced 2.99%	10,524 $396,000
Q2 2020 Aug 10, 2020	SELL	$37.87 - $43.58 $37,301 - $42,926	-985 Reduced 8.32%	10,848 $443,000
Q1 2020 Apr 30, 2020	BUY	$32.47 - $48.83 $1,266 - $1,904	39 Added 0.33%	11,833 $448,000
Q4 2019 Feb 03, 2020	SELL	$42.0 - $48.25 $32,466 - $37,297	-773 Reduced 6.15%	11,794 $554,000
Q3 2019 Nov 07, 2019	SELL	$40.46 - $43.52 $23,992 - $25,807	-593 Reduced 4.51%	12,567 $536,000
Q2 2019 Jul 09, 2019	SELL	$39.4 - $42.7 $64,458 - $69,857	-1,636 Reduced 11.06%	13,160 $527,000
Q1 2019 Apr 25, 2019	BUY	$38.57 - $42.69 $16,237 - $17,972	421 Added 2.93%	14,796 $618,000
Q4 2018 Feb 11, 2019	BUY	$37.8 - $42.69 $130,145 - $146,981	3,443 Added 31.49%	14,375 $549,000
Q3 2018 Oct 24, 2018	BUY	$39.75 - $42.69 $61,016 - $65,529	1,535 Added 16.34%	10,932 $439,000
Q2 2018 Aug 10, 2018	BUY	$39.61 - $42.76 $68,366 - $73,803	1,726 Added 22.5%	9,397 $391,000
Q1 2018 Apr 17, 2018	SELL	$36.18 - $40.15 $3,400 - $3,774	-94 Reduced 1.21%	7,671 $300,000
Q4 2017 Feb 05, 2018	BUY	$35.34 - $41.9 $274,415 - $325,353	7,765	7,765 $300,000

Others Institutions Holding GSK

# of Institutions

Shares Held

176K

Call Options Held

Put Options Held

View Full List

About GSK PLC

Ticker GSK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,033,689,984
Market Cap $69.2B
Description
GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceutic...

More about GSK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Calton & Associates, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Calton & Associates, Inc. with notifications on news.

Account